Log in to save to my catalogue

FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/ beta -Klotho Bispecific Protein....

FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/ beta -Klotho Bispecific Protein....

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1399917545

FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/ beta -Klotho Bispecific Protein. e61432

About this item

Full title

FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/ beta -Klotho Bispecific Protein. e61432

Journal title

PloS one, 2013-04, Vol.8 (4)

Language

English

Formats

Subjects

Subjects and topics

More information

Scope and Contents

Contents

The endocrine hormone FGF21 has attracted considerable interest as a potential therapeutic for treating diabetes and obesity. As an alternative to the native cytokine, we generated bispecific Avimer polypeptides that bind with high affinity and specificity to one of the receptor and coreceptor pairs used by FGF21, FGFR1c and beta -Klotho. These Avi...

Alternative Titles

Full title

FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/ beta -Klotho Bispecific Protein. e61432

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1399917545

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1399917545

Other Identifiers

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0061432

How to access this item